Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Rituximab is active in lymphocyte predominance Hodgkin's disease. Lucas, J. B., Hoppe, R. T., Horwitz, S. M., Breslin, S., Horning, S. J. AMER SOC HEMATOLOGY. 2000: 831A
View details for Web of Science ID 000165256103591